(Q35205519)

7 August 2017

1 reference

title

Treatment of older adults with acute promyelocytic leukaemia (English)

1 reference

7 August 2017

1 reference

2

Sylvie Chevret

1 reference

7 August 2017

Stéphane de Botton

3

0 references

Pierre Fenaux

series ordinal

1

object named as

Pierre Fenaux

1 reference

7 August 2017

1 September 2003

1 reference

Best Practice and Research: Clinical Haematology

7 August 2017

1 reference

7 August 2017

16

1 reference

7 August 2017

3

1 reference

7 August 2017

495-501

1 reference

All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

Treatment of Acute Promyelocytic Leukemia: A Report of 70 Cases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

All-trans retinoic acid and low-dose chemotherapy for acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 years

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900044-6

7 January 2021

10.1016/S1521-6926(03)00044-6

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12935965